ArticleFrontiers in oncology2023

Therapeutic strategies to overcome EGFR mutations as acquired resistance mechanism in ALK-rearranged non-small-cell lung cancer: Case Reports.

Lionel Michaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.